glp-1 cirrhosis GLP-1RA use linked to lower risk for cirrhosis, mortality in MASLD with diabetes Revolutionizing MASLD treatment with GLP-1

His work focuses on how microbial ecosystems interact with human physiology, including: Gut barrier function and intestinal permeability Mucus-associated microbiota (Akkermansia-related systems) Oralgut microbiome axis Short-chain fatty acids (SCFAs) and metabolic signaling Circadian rhythmmicrobiome interactions Clinical Research Contributions He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including: Active Ulcerative Colitis (Inflammatory Bowel Disease) Hyperoxaluria (Oxalate Metabolism Disorder) Microbiome-driven gut health and inflammatory conditions These studies were part of broader clinical development programs evaluating microbiome-based approaches

Related studies have indicated a causal relationship between IR and all clinical symptoms of PCOS, with weight loss being shown to improve the reproductive function, hyperandrogenism and metabolism of women with PCOS (155, 156)

Our medical experts will listen to your story and conduct a comprehensive evaluation to ensure a GLP-1 program is a safe and effective option for you

Seu uso indicado para tratar o diabetes tipo 2 , no sendo recomendada para emagrecimento